Bangkok Dusit Medical Services PCL (BKK:BDMS)
19.20
-0.20 (-1.03%)
At close: Mar 6, 2026
BKK:BDMS Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 111,507 | 107,867 | 100,853 | 91,934 | 74,451 | Upgrade
|
| Other Revenue | 1,699 | 1,484 | 1,258 | 1,034 | 1,263 | Upgrade
|
| Revenue | 113,206 | 109,351 | 102,110 | 92,968 | 75,714 | Upgrade
|
| Revenue Growth (YoY) | 3.53% | 7.09% | 9.83% | 22.79% | 11.22% | Upgrade
|
| Cost of Revenue | 71,261 | 68,071 | 63,412 | 58,329 | 49,497 | Upgrade
|
| Gross Profit | 41,946 | 41,280 | 38,698 | 34,638 | 26,217 | Upgrade
|
| Selling, General & Admin | 21,784 | 20,828 | 19,806 | 17,655 | 14,994 | Upgrade
|
| Operating Expenses | 21,784 | 20,828 | 19,806 | 17,655 | 14,994 | Upgrade
|
| Operating Income | 20,162 | 20,452 | 18,892 | 16,984 | 11,223 | Upgrade
|
| Interest Expense | -356.56 | -433.39 | -546.59 | -632.07 | -728.46 | Upgrade
|
| Interest & Investment Income | 179.5 | 236.55 | 216.88 | 87.93 | 77.72 | Upgrade
|
| Earnings From Equity Investments | 77.74 | 75.98 | 89.39 | 41.82 | 21.11 | Upgrade
|
| EBT Excluding Unusual Items | 20,063 | 20,331 | 18,652 | 16,481 | 10,594 | Upgrade
|
| Pretax Income | 20,063 | 20,331 | 18,652 | 16,481 | 10,594 | Upgrade
|
| Income Tax Expense | 3,694 | 3,792 | 3,772 | 3,227 | 2,103 | Upgrade
|
| Earnings From Continuing Operations | 16,368 | 16,539 | 14,880 | 13,254 | 8,490 | Upgrade
|
| Minority Interest in Earnings | -520.14 | -552.13 | -522.67 | -648.03 | -554.3 | Upgrade
|
| Net Income | 15,848 | 15,987 | 14,358 | 12,606 | 7,936 | Upgrade
|
| Net Income to Common | 15,848 | 15,987 | 14,358 | 12,606 | 7,936 | Upgrade
|
| Net Income Growth | -0.87% | 11.35% | 13.89% | 58.85% | 10.01% | Upgrade
|
| Shares Outstanding (Basic) | 15,892 | 15,892 | 15,892 | 15,892 | 15,892 | Upgrade
|
| Shares Outstanding (Diluted) | 15,892 | 15,892 | 15,892 | 15,892 | 15,892 | Upgrade
|
| EPS (Basic) | 1.00 | 1.01 | 0.90 | 0.79 | 0.50 | Upgrade
|
| EPS (Diluted) | 1.00 | 1.01 | 0.90 | 0.79 | 0.50 | Upgrade
|
| EPS Growth | -0.87% | 11.35% | 13.89% | 58.85% | 10.01% | Upgrade
|
| Free Cash Flow | 12,939 | 12,228 | 13,088 | 15,861 | 10,586 | Upgrade
|
| Free Cash Flow Per Share | 0.81 | 0.77 | 0.82 | 1.00 | 0.67 | Upgrade
|
| Dividend Per Share | 1.000 | 0.750 | 0.700 | 0.600 | 0.450 | Upgrade
|
| Dividend Growth | 33.33% | 7.14% | 16.67% | 33.33% | -18.18% | Upgrade
|
| Gross Margin | 37.05% | 37.75% | 37.90% | 37.26% | 34.63% | Upgrade
|
| Operating Margin | 17.81% | 18.70% | 18.50% | 18.27% | 14.82% | Upgrade
|
| Profit Margin | 14.00% | 14.62% | 14.06% | 13.56% | 10.48% | Upgrade
|
| Free Cash Flow Margin | 11.43% | 11.18% | 12.82% | 17.06% | 13.98% | Upgrade
|
| EBITDA | 26,554 | 26,141 | 24,337 | 22,512 | 17,073 | Upgrade
|
| EBITDA Margin | 23.46% | 23.91% | 23.83% | 24.21% | 22.55% | Upgrade
|
| D&A For EBITDA | 6,392 | 5,689 | 5,445 | 5,528 | 5,850 | Upgrade
|
| EBIT | 20,162 | 20,452 | 18,892 | 16,984 | 11,223 | Upgrade
|
| EBIT Margin | 17.81% | 18.70% | 18.50% | 18.27% | 14.82% | Upgrade
|
| Effective Tax Rate | 18.41% | 18.65% | 20.22% | 19.58% | 19.86% | Upgrade
|
| Revenue as Reported | 113,272 | 109,413 | 102,154 | 92,976 | 75,719 | Upgrade
|
| Advertising Expenses | 0.95 | 1.05 | 914 | 718 | 499 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.